Home NDC 55150-286 Cisatracurium Besylate
Product NDC 55150-286
11-digit product format 551500286
Labeler code 55150
Product ID 55150-286_d40d8c7d-32a9-4518-9043-766790c1037c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Cisatracurium Besylate
Dosage form INJECTION
Route INTRAVENOUS
Labeler Eugia US LLC
Application ANDA209144
Marketing category ANDA
Marketing start 2020-05-08
Substance CISATRACURIUM BESYLATE
Active strength 20 mg/10mL
Pharmacologic classes Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A209144-001 CISATRACURIUM BESYLATE CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION 2020-05-08
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION 2020-05-08 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION 2020-05-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION 2020-05-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION 2020-05-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 c0c555d07b60…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION AP 2020-05-08 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A209144-001 CISATRACURIUM BESYLATE EQ 2MG BASE/ML INJECTABLE / INJECTION 2020-05-08 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Cisatracurium Besylate
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CISATRACURIUM BESYLATE 20 mg/10mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 80YS8O1MBS Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 199211 Internal RxNorm lookup 1730194 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 55150-286-01 Cisatracurium Besylate 10 mL in 1 VIAL, MULTI-DOSE INJECTION 10 6 55150-286-10 Cisatracurium Besylate 10 in 1 CARTON INJECTION 10 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 55150-286 CISATRACURIUM BESYLATE INJECTION [EUGIA US LLC] 5 Current NDC, Legacy NDC, 2 package rows 20240515_2cb05c7e-6228-4e2d-a270-7659e3db3fa7.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 55150-286-01 55150028601 10 mL in 1 VIAL, MULTI-DOSE 10 ml Historical 55150-286-10 55150028610 10 VIAL, MULTI-DOSE in 1 CARTON (55150-286-10) / 10 mL in 1 VIAL, MULTI-DOSE (55150-286-01) 2020-05-08 0000-00-00 No No Current